Seroepidemiological and genomic investigation of SARS-CoV-2 spread in North East region of India

Murhekar, 2021, SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey, Lancet Global Health, 9, e257, 10.1016/S2214-109X(20)30544-1 Genome sequencing by INSACOG shows variants of concern and a novel variant in India, 2021 2021 Tessema, 2020, Accelerating genomics-based surveillance for COVID-19 response in Africa, Lancet Microbe, 1, e227, 10.1016/S2666-5247(20)30117-8 2021 Indian COVID-19 Genome Surveillance, 2021 2021 Tyson, 2020, Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore, bioRxiv, 2020 Mahanta, 2022, COVID-19 impact on socio-economic and health interventions: A gaps and peaks analysis using clustering approach, J Statistics Manag Syst, 25, 2123, 10.1080/09720510.2022.2117335 Mlcochova, 2021, SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion, Nature, 599, 114, 10.1038/s41586-021-03944-y Naushin, 2021, Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2, Elife, 10, 10.7554/eLife.66537 Singh, 2022, A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveys, Comput Biol Med, 146, 1054419, 10.1016/j.compbiomed.2022.105419 Planas, 2021, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization, Nature, 596, 276, 10.1038/s41586-021-03777-9 Merler, 2008, Coinfection can trigger multiple pandemic waves, J Theor Biol, 254, 499, 10.1016/j.jtbi.2008.06.004 Al-Tammemi, 2021, A swaying between successive pandemic waves and pandemic fatigue: where does Jordan stand?, Ann Med Surg (Lond), 65 Cacciapaglia, 2021, Multiwave pandemic dynamics explained: how to tame the next wave of infectious diseases, Sci Rep, 11, 10.1038/s41598-021-85875-2 Pietro, 2021, Genetic drift versus regional spreading dynamics of COVID-19, Front Genet, 12, 10.3389/fgene.2021.663371 Harvey, 2021, SARS-CoV-2 variants, spike mutations and immune escape, Nat Rev Microbiol, 19, 409, 10.1038/s41579-021-00573-0 Cherian, 2021, SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India, Microorganisms, 9, 1542, 10.3390/microorganisms9071542 Wang, 2021, Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients, Int Immunopharm, 90, 10.1016/j.intimp.2020.107271 Xiao, 2021, Antibodies can last for more than 1 year after SARS-CoV-2 infection: a follow-up study from survivors of COVID-19, Front Med, 8 Reynolds, 2021, Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose, Science, 372, 1418, 10.1126/science.abh1282 Goel, 2021, Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination, Sci Immunol, 6, 10.1126/sciimmunol.abi6950 Turner, 2021, SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses, Nature, 596, 109, 10.1038/s41586-021-03738-2 Challen, 2021, Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B.1.617.2 in England, medRxiv, 2021 Lopez Bernal, 2021, Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant, N Engl J Med, 385, 585, 10.1056/NEJMoa2108891 Yang, 2021, COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination, medRxiv, 2021 Yadav, 2021, SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant, bioRxiv, 2021 Starr, 2020, Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding, Cell., 182, 1295, 10.1016/j.cell.2020.08.012 Mallapaty, 2021, India's neighbours race to sequence genomes as COVID surges, Nature, 593, 485, 10.1038/d41586-021-01287-2 Saha, 2021, COVID-19 rise in Bangladesh correlates with increasing detection of B.1.351 variant, BMJ Glob Health, 6, 10.1136/bmjgh-2021-006012